Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model-Reference-Cited by-同舟云学术

Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model

Published:2017-09-11 Issue:1 Volume:39 Page:47-55
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Shimizu Yoshiko¹²³,Furuya Hideki¹²^ORCID,Tamashiro Paulette M¹,Iino Kayoko¹,Chan Owen T M²,Goodison Steve⁴,Pagano Ian⁵,Hokutan Kanani²³,Peres Rafael²,Loo Lenora W M⁶,Hernandez Brenda⁶,Naing Aung⁷,Chong Clayton D K⁶,Rosser Charles J²,Kawamori Toshihiko¹³⁸

Affiliation:

1. Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA

2. Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, USA

3. Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, USA

4. Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA

5. Cancer Prevention and Control Program, University of Hawaii Cancer Center, Honolulu, HI, USA

6. Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA

7. Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

8. Shonan Medical Clinic, Sonezakishinnchi, Kita-ku, Osaka, Japan

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/39/1/47/24346887/bgx097.pdf

Reference51 articles.

1. Cancer statistics, 2016;Siegel;CA. Cancer J. Clin,2016

2. The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy;Mitri;Chemother. Res. Pract,2012